Projected Income Statement: Tate & Lyle plc

Forecast Balance Sheet: Tate & Lyle plc

Fiscal Period: March 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 417 626 238 153 961 891 813 720
Change - 50.12% -61.98% -35.71% 528.1% -7.28% -8.75% -11.44%
Announcement Date 27/05/21 09/06/22 25/05/23 23/05/24 22/05/25 - - -
1GBP in Million
Estimates

Cash Flow Forecast: Tate & Lyle plc

Fiscal Period: March 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 152 148 78 101 114 128.2 137.4 145.1
Change - -2.63% -47.3% 29.49% 12.87% 12.43% 7.21% 5.59%
Free Cash Flow (FCF) 1 217 -45 -12 107 50 170.1 201.1 204.1
Change - -120.74% 73.33% 991.67% -53.27% 240.13% 18.23% 1.5%
Announcement Date 27/05/21 09/06/22 25/05/23 23/05/24 22/05/25 - - -
1GBP in Million
Estimates

Forecast Financial Ratios: Tate & Lyle plc

Fiscal Period: March 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 17.96% 34.18% 18.28% 19.91% 21.95% 20.65% 21.39% 21.84%
EBIT Margin (%) 12.08% 22.69% 14.22% 15.66% 16.59% 13.91% 14.7% 15.21%
EBT Margin (%) 10.08% 3.05% 8.68% 13.72% 5.07% 9.25% 11.33% 12.42%
Net margin (%) 9.01% 17.16% 10.85% 11.41% 8.24% 6.06% 7.91% 8.7%
FCF margin (%) 7.73% -3.27% -0.69% 6.5% 2.88% 8.44% 9.78% 9.56%
FCF / Net Income (%) 85.77% -19.07% -6.32% 56.91% 34.97% 139.38% 123.67% 109.93%

Profitability

        
ROA 8.68% 7.59% 6.6% 7.85% 4.76% 3.53% 5.05% 5.49%
ROE 17.7% 15.36% 14.46% 15.49% 10.11% 10.29% 11.23% 11.86%

Financial Health

        
Leverage (Debt/EBITDA) 0.83x 1.33x 0.74x 0.47x 2.52x 2.14x 1.85x 1.54x
Debt / Free cash flow 1.92x -13.91x -19.83x 1.43x 19.22x 5.24x 4.04x 3.53x

Capital Intensity

        
CAPEX / Current Assets (%) 5.42% 10.76% 4.45% 6.13% 6.57% 6.36% 6.68% 6.8%
CAPEX / EBITDA (%) 30.16% 31.49% 24.38% 30.79% 29.92% 30.82% 31.23% 31.11%
CAPEX / FCF (%) 70.05% -328.89% -650% 94.39% 228% 75.37% 68.34% 71.09%

Items per share

        
Cash flow per share 1 0.9171 0.219 0.1604 0.5146 0.3949 0.668 0.8249 0.8496
Change - -76.13% -26.74% 220.82% -23.26% 69.15% 23.5% 2.98%
Dividend per Share 1 0.3593 0.218 0.185 0.191 0.198 0.2029 0.2071 0.213
Change - -39.33% -15.14% 3.24% 3.66% 2.46% 2.08% 2.85%
Book Value Per Share 1 3.667 3.481 2.942 3.063 3.829 3.657 3.833 4.044
Change - -5.07% -15.48% 4.1% 25% -4.49% 4.82% 5.5%
EPS 1 0.6277 0.502 0.462 0.465 0.345 0.2757 0.3679 0.4201
Change - -20.02% -7.97% 0.65% -25.81% -20.08% 33.41% 14.19%
Nbr of stocks (in thousands) 397,116 398,170 398,150 397,704 441,667 441,685 441,685 441,685
Announcement Date 27/05/21 09/06/22 25/05/23 23/05/24 22/05/25 - - -
1GBP
Estimates
2026 *2027 *
P/E ratio 14.4x 10.8x
PBR 1.08x 1.03x
EV / Sales 1.31x 1.25x
Yield 5.12% 5.22%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
3.964GBP
Average target price
5.007GBP
Spread / Average Target
+26.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. TATE Stock
  4. Financials Tate & Lyle plc